Vanguard Group Inc Alector, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Alector, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,912,578 shares of ALEC stock, worth $22.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,912,578

Previous 4,386,541 11.99%

Holding current value

$22.3 Million

Previous $35 Million 15.52%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$5.69 - $8.08 $2.99 Million - $4.25 Million	526,037 Added 11.99%	4,912,578 $29.6 Million
Q4 2023 Feb 14, 2024	SELL	$3.77 - $8.39 $4.28 Million - $9.52 Million	-1,134,367 Reduced 20.55%	4,386,541 $35 Million
Q3 2023 Nov 14, 2023	SELL	$5.2 - $8.77 $5.76 Million - $9.71 Million	-1,107,318 Reduced 16.71%	5,520,908 $35.8 Million
Q2 2023 Aug 14, 2023	BUY	$5.86 - $7.93 $1.31 Million - $1.78 Million	224,063 Added 3.5%	6,628,226 $39.8 Million
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $231,379 - $389,191	39,552 Added 0.62%	6,404,163 $39.6 Million

Q4 2022 Feb 10, 2023	BUY	$6.88 - $9.55 $4.21 Million - $5.84 Million	611,417 Added 10.63%	6,364,611 $58.7 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $364,438 - $587,373	44,498 Added 0.78%	5,753,194 $54.4 Million
Q2 2022 Aug 12, 2022	BUY	$7.65 - $14.24 $2.03 Million - $3.77 Million	264,773 Added 4.86%	5,708,696 $58 Million
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $1.25 Million - $2 Million	-96,317 Reduced 1.74%	5,443,923 $77.6 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $8.96 Million - $11.8 Million	462,807 Added 9.11%	5,540,240 $114 Million
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $3.16 Million - $5.77 Million	146,113 Added 2.96%	5,077,433 $116 Million
Q2 2021 Aug 13, 2021	BUY	$15.5 - $22.48 $76.4 Million - $111 Million	4,931,320 New	4,931,320 $103 Million

Others Institutions Holding ALEC

# of Institutions

161

Shares Held

59.8M

Call Options Held

67.8K

Put Options Held

200

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $375M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Alector, Inc. Transaction History